2250342-36-8
2250342-36-8
Chemical Structure
Vulinacimab
Synonym(s): HLX-06
- CAS No.: 2250342-36-8
- Formula:N/A
- Molecular Weight:(145.28 kDa)
SMILES: [Vulinacimab]
Biological Activity:
Vulinacimab (HLX-06) is a human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2). Vulinacimab specifically binds to and inhibits VEGFR-2, which may inhibit tumor angiogenesis and tumor cell proliferation. Vulinacimab can be used for the research of solid tumors and non-small cell lung cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vulinacimab | 99.40% | Vulinacimab (HLX-06) is a human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2). Vulinacimab specifically binds to and inhibits VEGFR-2, which may inhibit tumor angiogenesis and tumor cell proliferation. Vulinacimab can be used for the research of solid tumors and non-small cell lung cancer. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
